Arima Kuga, Akiyama Satoko, Shin-Ya Kazuo, Matsuda Kenichi, Wakimoto Toshiyuki
Faculty of Pharmaceutical Sciences, Hokkaido University, Kita 12, Nishi 6, Kita-ku, Sapporo, 060-0812, Japan.
National Institute of Advanced Industrial Science and Technology (AIST), Tokyo, 135-0064, Japan.
Angew Chem Int Ed Engl. 2023 Jul 17;62(29):e202305155. doi: 10.1002/anie.202305155. Epub 2023 Jun 6.
Heterocycles with nitrogen-nitrogen (N-N) bonds are privileged building blocks of synthetic drugs. They are also found in natural products, although the biosynthetic logic behind them is poorly understood. Actinopyridazinones produced by Streptomyces sp. MSD090630SC-05 possess unique dihydropyridazinone rings that have been studied as core nuclei in several approved synthetic therapeutics. Herein, we performed gene knockouts and in vitro biochemical experiments to elucidate the major steps in actinopyridazinone biosynthesis, including the unprecedented carrier protein mediated machinery for dihydropyridazinone formation.
含有氮-氮(N-N)键的杂环是合成药物的重要组成部分。它们也存在于天然产物中,尽管其背后的生物合成逻辑尚不清楚。链霉菌属MSD090630SC-05产生的放线菌哒嗪酮具有独特的二氢哒嗪酮环,该环已在几种已批准的合成治疗药物中作为核心核进行了研究。在此,我们进行了基因敲除和体外生化实验,以阐明放线菌哒嗪酮生物合成的主要步骤,包括前所未有的载体蛋白介导的二氢哒嗪酮形成机制。